Ifp Advisors, Inc Atossa Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$2.89 - $6.4 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$1.52 - $8.62 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$0.92 - $4.33 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$0.85 - $2.43 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$1.98 - $4.35 $0 - $0	0 New

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $111M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.